Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trial
卡纳单抗治疗合并 COVID-19 和 2 型糖尿病患者的多中心、随机、双盲、安慰剂对照试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2022.101649
Hepprich, Matthias; Mudry, Jonathan M; Gregoriano, Claudia; Jornayvaz, Francois R; Carballo, Sebastian; Wojtusciszyn, Anne; Bart, Pierre-Alexandre; Chiche, Jean-Daniel; Fischli, Stefan; Baumgartner, Thomas; Cavelti-Weder, Claudia; Braun, Dominique L; Günthard, Huldrych F; Beuschlein, Felix; Conen, Anna; West, Emily; Isenring, Egon; Zechmann, Stefan; Bucklar, Gabriela; Aubry, Yoann; Dey, Ludovic; Müller, Beat; Hunziker, Patrick; Schütz, Philipp; Cattaneo, Marco; Donath, Marc Y
